Alps Advisors Inc
- SEC CIK
- 0001376113
- Latest filing
- Jul 29, 2026
AVXL holding history
Anavex Life Sciences Corp. in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVXL overviewAll 13F holders of AVXLFull Q2 2026 holdings
- Shares (Q2 2026)
- 94,051
- Value
- $243.6K
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 94,051 | $243.6K | <0.1% | +18,608+24.7% | Added | Holders |
| Q1 2026 | 75,443 | $231.6K | <0.1% | +2,082+2.8% | Added | Holders |
| Q4 2025 | 73,361 | $261.2K | <0.1% | +34,755+90.0% | Added | Holders |
| Q3 2025 | 38,606 | $343.6K | <0.1% | −7,474−16.2% | Reduced | Holders |
| Q2 2025 | 46,080 | $424.9K | <0.1% | −14,140−23.5% | Reduced | Holders |
| Q1 2025 | 60,220 | $516.7K | <0.1% | −8,346−12.2% | Reduced | Holders |
| Q4 2024 | 68,566 | $736.4K | <0.1% | +4,587+7.2% | Added | Holders |
| Q3 2024 | 63,979 | $363.4K | <0.1% | −2,070−3.1% | Reduced | Holders |
| Q2 2024 | 66,049 | $278.7K | <0.1% | +8,136+14.0% | Added | Holders |
| Q1 2024 | 57,913 | $294.8K | <0.1% | +1,782+3.2% | Added | Holders |
| Q4 2023 | 56,131 | $522.6K | <0.1% | −4,320−7.1% | Reduced | Holders |
| Q3 2023 | 60,451 | $396.0K | <0.1% | +1,031+1.7% | Added | Holders |
| Q2 2023 | 59,420 | $483.1K | <0.1% | +8,007+15.6% | Added | Holders |
| Q1 2023 | 51,413 | $440.6K | <0.1% | −1,511−2.9% | Reduced | Holders |
| Q4 2022 | 52,924 | $490.1K | <0.1% | +10,424+24.5% | Added | Holders |
| Q3 2022 | 42,500 | $439.0K | <0.1% | −3,426−7.5% | Reduced | Holders |
| Q2 2022 | 45,926 | $460.0K | <0.1% | −32,360−41.3% | Reduced | Holders |
| Q1 2022 | 78,286 | $964.0K | <0.1% | −9,686−11.0% | Reduced | Holders |
| Q4 2021 | 87,972 | $1.52M | <0.1% | +87,972 | New | Holders |